Introduction
The generation of hematopoietic cells requires the coordinate interplay of many regulatory molecules which are secreted and/or remain cell associated in the bone marrow. Importance for stromal cells in the production of these molecules has been deduced from in vitro experiments aiming at mimicking the bone marrow microenvironment such as long-term bone marrow cultures (LTBMC). 1 The differentiation and proliferation of hematopoietic progenitor cells critically relies on a functional stromal layer. [2] [3] [4] [5] [6] A direct contact between hematopoietic progenitors and the stromal layer is not an absolute condition for the proliferation and differentiation of hematopoietic progenitors. A non-contact culture system is also efficient. 7, 8 These experiments demonstrated that soluble factors secreted by the bone marrow Correspondence stroma were essential to hematopoiesis. Among these are cytokines which have been shown to support in vitro hematopoiesis when they are used in combination. 9 The mRNA transcripts for most of these cytokines have been found in stromal cells. Secretion of bioactive molecule by bone marrow stroma cells was demonstrated for some of them. [10] [11] [12] [13] [14] [15] [16] Other stromaderived growth factors are supposed to be necessary for optimal expansion of hematopoietic progenitors.
The bone marrow stroma has a heterogeneous composition. It is made of fibroblasts, EC, [17] [18] [19] [20] [21] [22] [23] and other cells present in smaller number but with potentially functional importance, such as adipocytes, macrophages and osteoclasts. Such complexity makes the task of identifying which cytokines are secreted by which cell and how their production are regulated difficult. Stroma-derived cell lines have proven to be useful as a simplified model for these studies. Clonal stromal cell lines from the hematopoietic environment, either of human or murine origin, have been shown to be able to support growth of primitive human hematopoietic progenitors. [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] However, these cell lines may not accurately reflect their in vivo counterparts. One of the major problems associated with cell lines is the possibility of extensive genetic change that they may undergo in culture. This is probably one reason for the large variation observed in the ability of stromal cell lines to support hematopoiesis. 35, 36 A further limitation for murine cell lines may be the incomplete species cross-reactivity of hematopoietic growth factors.
EC have been shown to produce many of the cytokines which are known to play a role in the proliferation and differentiation of hematopoietic progenitors. [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] The functional importance of this production remains to be fully appreciated. As a direct relevant application, EC may for instance offer an improved alternative to unfractionated stroma cells as a source of feeder cells in bioreactors devised for ex vivo expansion of hematopoietic progenitors. In this report we have studied the capacity of EC to support human hematopoiesis in vitro and have tried to answer the question whether this support was directly and exclusively linked to the production of hematopoietic growth factors using comparative coculture experimental settings and antibody neutralizing experiments. We have analyzed the modulation of this capacity by IL-1 and GC. We show that addition of exogenous cytokines to EC/hematopoietic progenitor cocultures induced a synergistic increase in cell proliferation and generation of CFC resulting in the generation of a large number of clonogenic cells and that EC may produce hitherto uncharacterized soluble factors that potentiate a combination of cytokines including IL-1, IL-6, IL-3, IL-11, G-CSF, GM-CSF, M-CSF, flt3-ligand, SCF and TPO. The potential usefulness of EC for protocols aiming at improving the ex-vivo expansion of hematopoietic progenitors is discussed.
Cord blood and bone marrow specimens
Umbilical cord blood was obtained during normal full-term deliveries with the mothers' informed consent. After placental delivery, the umbilical veins were canulated and aspirated. Blood was collected into physiologic saline containing preservative-free heparine and stored at 4°C. The samples were processed within 12 h of collection.
Normal fresh BM samples were collected from individuals undergoing orthopedic surgery or donating BM for allogeneic BM transplantation. Informed consent was obtained from each donor.
Isolation of CD34
+ cells and CD34 + /CD38 low cells
Low density mononuclear cells were isolated by layering bone marrow or cord blood over Ficoll-Hypaque (density 1.077g/cm 3 ; Seromed, Biochrom KG, Berlin, Germany). Hematopoietic progenitors expressing the CD34 antigen were obtained by an immunomagnetic isolation system (Isolex 50; Baxter, Maurepas, France), according to the manufacturer's instructions. The purity of the isolated population was assessed by cytofluorimetry after staining with anti-CD34 monoclonal antibody HPCA-2-FITC (Becton Dickinson, Pontde-Claix, France). Only preparations giving 85% purity or more were used. Isolated cells were then used immediately for coculture with EC or for cell sorting. To isolate CD34 + /CD38 low cells, a two-color staining of immunomagnetically isolated CD34
+ cells was performed with anti-CD34-FITC monoclonal antibody (HPCA-2), anti-CD38-PE monoclonal antibody (Leu-7; Becton Dickinson). Cells were incubated for 30 min at +4°C and washed twice. Negative controls were labelled with appropriate isotypic controls. Cells were sorted on a PC 3000 cell sorter (Odam-Brucker, Wissenbourg, France).
EC from the umbilical cord
HUVEC were obtained from freshly collected umbilical cords. 0.1% w/v collagenase (Boehringer Mannheim, Meylan, France) was used for treatment of the umbilical vein instead of 0.2%, as originally described. 48 They were cultured in IMDM (Iscove's modified Dulbecco's medium; Gibco, Cergy-Pontoise, France) supplemented with 15% heat-inactivated foetal calf serum (FCS), 90 g/ml heparin (Sigma), penicillin (100 g/ml), streptomycin (100 g/ml), amphotericin B (2.5 g/ml). This culture medium is referred to as standard medium. Cells were grown to confluence in 75 or 25 cm 2 flasks coated with 50 g/ml collagen I (Jacques Boy Institute, Paris, France). Cells were passaged after treatment with trypsin-EDTA and routinely used between the second and fourth passages. After the second passage, there was no visible contamination by monocytes. Cells were maintained in a humidified atmosphere at 37°C, 5% CO 2 , and were identified by their characteristic morphology and by the expression of Factor VIII antigen.
EC from the bone marrow microvasculature
EC from human bone marrow (BM) microvasculature (BMEC) were isolated following a two-step procedure with BNH-9 or S-Endo-1-coated microspheres. BNH-9 is a mouse IgM monoclonal antibody recognizing EC-specific H and Y antigens (Immunotech, Marseille, France). S-Endo-1 is a monoclonal antibody reactive with a 110 kDa protein expressed at the membrane of HUVEC (Biocytex, Marseille, France). The whole procedure is essentially the same as described by Rafii et al 49 and Schweitzer et al. 50 Briefly, the BM sample (5-30 ml total) was diluted 1:1 in Buffer A (RPMI containing 5 mM EDTA) and placed on a 40 m Cell Strainer Falcon disposable filter, washed five times with Buffer A while being gently triturated. Mononuclear cells (MNC) were separated from filtrate by standard Ficoll-Hypaque centrifugation at 400 g for 20 min at 24°C, and kept for further isolation as they also contain HBMEC. To avoid binding of the BM fat ladder spicules to the surfaces, plastic wares at this step were treated with 1% BSA in RPMI. The filter was cut out, placed in a 50 ml Falcon tube and digested in 10 ml of 0.1% collagenase for 15 min at 37°C. The digested material was gently passaged several times through a 1 ml tip. This material was washed twice with RPMI containing 2% FCS and then gently triturated to further dissociate the EC.
HBMEC were further isolated by positive selection using BNH-9 or S-Endo1 monoclonal antibody. This protocol gives a highly enriched population of BMEC.
50 EC were collected, washed once with complete medium and plated in collagencoated dishes or flasks as above, on collagen I coated 6-well Nunc plastic dishes in IMDM containing 20% FCS, 15 g/ml ECGF, 90 g/ml heparin, antibiotics and amphotericine B. Forskolin and IBMX (Sigma, St Quentin Fallavier, France) were added at the beginning of the cultures at final concentrations of 0.5 M, to inhibit fibroblastic growth. m final concentrations. Cultures were fed twice a week by removing 2 ml of medium and replacing it with fresh medium with or without IL-1␣ or DXM as indicated. At time intervals, cells were recovered from the inserts by vigorous washing and resuspended in IMDM supplemented with 10% FCS. Cells were counted under a hemocytometer, tested for viability by Trypan blue exclusion, phenotyped and plated in methylcellulose cultures for clonogenic assays. In some experiments a combination of IL-1␣ (100 IU/ml), IL-6 (10 ng/ml), IL-3 (50 ng/ml), IL-11 (10 ng/ml), SCF (50 ng/ml), flt3-ligand (100 ng/ml), TPO (10 ng/ml), G-CSF (50 ng/ml), GM-CSF (10 ng/ml), M-CSF (10 ng/ml) was added to the culture medium.
For measurements of cytokine concentrations, the coculture medium was recovered at indicated time intervals, centrifuged for 30 min at 50 000 g, 4°C, decanted to a clean tube and frozen at −80°C until further use. Finally, in some experiments, EC were prestimulated for 36 h with IL-1␣ then washed five times to remove IL-1␣ and cocultivated with the hematopoietic progenitors as above.
Contact cocultures:
In contact cocultures hematopoietic progenitors were directly added on to the EC monolayer in a total volume of 5 ml in the presence or absence of IL-1␣ at a concentration of 100 IU/ml or DXM at a concentration of 10
M. Cultures were maintained and fed as above. At the indicated time intervals, non-adherent cells were collected for numeration, methylcellulose colony-forming assay, phenotyping, or morphologic analysis. Adherent cells were detached together with the EC monolayer by trypsinization, quantified under a hemocytometer and analyzed for their clonogenic progenitor content by methylcellulose colony-forming assay.
Long-term cocultures:
For long-term cocultures, the EC together with the adherent population of progenitors were trypsinized and reseeded on a confluent fresh layer of EC. Routinely, cells were trypsinized every 10 days to 2 weeks.
Hematopoietic progenitor proliferation in the presence of EC supernatants:
Isolated CD34 + progenitors were grown in liquid culture in the presence of 25% EC supernatants in DMEM supplemented with 15% FCS and antibiotics. In some experiments, a combination of IL-1␣ (100 IU/ml), IL-6 (10 ng/ml), IL-3 (50 ng/ml), IL-11 (10 ng/ml), SCF (50 ng/ml), flt3-ligand (100 ng/ml), TPO (10 ng/ml), G-CSF (50 ng/ml), GM-CSF (10 ng/ml), M-CSF (10 ng/ml) was added to the culture medium.
Cytokine neutralization experiments:
For inhibition studies with neutralizing anti-cytokine antibodies a mixture of neutralizing polyclonal antibodies directed against IL-1␣, IL-1␤, IL-6, IL-11, G-CSF, GM-CSF, M-CSF, SCF and LIF was added to the culture medium. Experiments were performed in 6-well plates. Final concentrations for each neutralizing antibody was 5 g/ml. Antibodies were readded at the same final concentrations when refeeding the coculture. This mixture of antibodies when used in the range of 5 g/ml final for each antibody, gave efficient neutralization of a combination of recombinant human IL-1␣, IL-1␤, IL-6, IL-11, G-CSF, GM-CSF, M-CSF, SCF and LIF at concentrations of 50 ng/ml each.
Preparation of LTBMC and other cells
For experiments aimed at comparing EC and human bone marrow stroma for their ability to support proliferation and generation of CFC, human marrow adherent cells were derived from 4 to 6 week-old human LTBMC. LTBMC were established in 25 cm 2 tissue culture flasks from light-density bone marrow cells. Culture medium was IMDM supplemented with 12.5% FCS, 12.5% horse serum, penicillin (100 g/ml), streptomycin (100 g/ml), kanamycin (100 g/ml), amphotericin B (2.5 g/ml) and 10 −7 M hydrocortisone (HC) (Sigma). Semi-confluent stromal layers were trypsinized, replated in 6-well plates and grown until confluency. Cells were then washed five times to remove HC and used for non-contact coculture with hematopoietic progenitors in parallel with EC as described above. Normal human fibroblasts were isolated from foreskins using standard protocols.
In vitro methylcellulose colony-forming assay
The frequency of CFU-GM progenitors was enumerated in semi-solid methylcellulose cultures containing IL-1␣ (500 IU/ml), SCF (10 ng/ml), IL-3 (10 ng/ml) and G-CSF (10 ng/ml). In brief, cells were plated in 35-mm Petri culture dishes (Falcon, Subra, Toulouse, France) containing IMDM supplemented with 10% FCS, 0.4% human serum albumin (Inter Transfusion, Bordeaux, France) and 0.88% methylcellulose (Sigma). Colonies (Ͼ40 cells) were scored on day 14. All cultures were performed in triplicate. To analyze the expansion of clonogenic progenitor cells by the coculture supernatants, mononuclear cells or CD34 + cells from normal human marrow were plated as above in methylcellulose containing 15% (v/v) of the coculture supernatants or the cocktail of cytokines described above and colonies were scored at day 14.
Flow cytometry
Hematopoietic cells obtained as described above were incubated with saturating doses of conjugated monoclonal antibodies for 30 min at 4°C. Cells were washed two times with PBS/BSA 0.1% and analyzed on a EPICS XL (Coulter) flow cytometer. To eliminate possible interference with EC which might have detached, staining was gated on CD45 + cells. Antibodies used were Leu-M9 (anti-CD33; Becton Dickinson), Leu-M3 (anti-CD14, Becton Dickinson), Leu-12 (anti-CD19, Becton Dickinson), 69 (Plt-1) (anti-CD41, Coulter Immunotech (Marseille, France)), Anti-Hle-1 (anti-CD45, Becton Dickinson).
Morphological analysis
Morphological analysis was performed by conventional microscopic analysis of May-Grü nwald Giemsa-stained cytospin preparations.
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Cytokine measurements
Cytokine concentrations in EC supernatants were measured by EIA. EIA kits were purchased from Immunotech for IL-1␤, IL-6, GM-CSF quantifications, R&D systems for G-CSF and M-CSF quantifications and BioEnviroTech (Allauch, France) for IL-7 and IL-3 quantifications. Measurements were done according to the manufacturer's instructions.
Statistical analysis
Results of experimental points obtained from multiple experiments were reported as the mean ± standard error of the mean (s.e.m.). Significant differences between values obtained in each assay were determined by unpaired Student's t-test for samples with equal variance. Differences were considered as significant when P Ͻ 0.05.
Results

EC secretory products efficiently support the expansion of nucleated cells and CFC
CD34
+ cells were resuspended in standard medium and placed in Transwell inserts above confluent EC monolayers. For each experiment the EC came from different donors. The coculture was maintained for a time period of up to 3 weeks. Regular visual inspection showed that no adherent EC layer formed in the Transwell insert within this period of time. Cell expansion was measured at 7, 14 and 21 day intervals. A progressive, sustained and important cell expansion of the nucleated cells was seen (Figure 1a) . Cell expansion was routinely above 1000-fold after 3 weeks of coculture. The progressive expansion of cell number contrasted with the very rapid expansion that could be observed when hematopoietic progenitors were added with a combination of cytokines known to directly induce proliferation of progenitors, in the absence of an EC monolayer (below). These results were consistent with the hypothesis that the EC layer promoted the progenitor expansion by producing cytokines, the concentration of which built up progressively with time and the degree of expansion being proportional to the concentration of these cytokines. Similar results were obtained with CD34 + /CD38 low cells (3.1 ± 0.6, 59 ± 22, 1005 ± 401 expansion of the nucleated cells at days 7, 14, 21, respectively, average ± s.e.m. of three independent experiments). To rule out a possible contact occurring through the pore of the Transwell by EC which might have detached from the monolayer, control experiments were performed with cells separated by two sets of Transwell filters; these experiments did not show any differences.
Larger coculture periods, up to 8 weeks, generated a large number of hematopoietic cells. Kinetics of cell expansion showed that after the initial rapid increase in cell number until week 3 there was a progressive decline in the rate of expansion (fold cell expansion 136 ± 4 at week 4 and 12 ± 4 at week 8). Starting with 5000 CD34
+ cells, the cumulated total number of cells was over 10
7 . The EC monolayer tends to detach after 3 weeks of culture. This could be resolved by transferring the hematopoietic cells to a fresh layer of EC every second week. Another way of preventing detachment of the EC monolayer was to add DXM to the coculture medium. We observed that this addition at a final concentration of 10 −6 M had a detachment-preventive effect. However, a drawback of the use of glucocorticosteroids (GC) in these experiments is that they significantly reduced cell expansion and the generation of clonogenic cells (see below, Results section).
To analyze the amplification of clonogenic precursors, cells were recovered from inserts after 1, 2 and 3 weeks of coculture and an aliquot replated in methylcellulose for clonogenic progenitor cell assay. There was a progressive amplification of the number of clonogenic cells with time that paralleled the increase in total cell number. This increase in CFC could be sustained for 2-3 weeks (Figure 1b) . After 3 weeks there was a progressive decrease in the number of clonogenic cells suggesting that EC secretory products promote rapid differentiation of the progenitors (fold CFU-GM expansion 11 ± 3 week 4, no CFU-GM at week 8). The EC were not able to maintain erythroid progenitors in such a non-contact coculture system as there was an immediate decrease in the number of BFU-E. Similar results were obtained with CD34 + /CD38 low cells (3.5 ± 0.44, 7.3 ± 2.1, 14.7 ± 2.1 expansion of the CFU-GM at days 7, 14, 21, respectively, average ± s.e.m. of three independent experiments). BMEC also supported the proliferation of hematopoietic progenitors. However, expansions of both total nucleated cells and CFC were consistently lower with BMEC than with HUVEC ( Figure 1c and d) . In short-term 3-week-old cocultures, progenitor cell expansion was higher in HUVEC/progenitor cocultures than in bone marrow stroma/progenitor cocultures (6.5-fold difference at day 21, average of two independent experiments) or fibroblast/ progenitor cocultures (3-fold difference at day 21, average of two independent experiments).
Progenitor cell expansion and CFC generation in contact cocultures
In the non-adherent population both cell proliferation and generation of clonogenic cells were increased for a period of up to 3 weeks (Figure 2a and b) . As in non-contact cocultures there was a peak of expansion at week 3 followed by a progressive decline (fold cell expansion 326 ± 14 at week 4 and 26.4 ± 1.6 at week 8). Starting with 5000 CD34 + cells, the cumulated total number of cells was over 10
8 . The generation of clonogenic cells reached a maximum at 2 weeks and then declined (fold CFU-GM expansion 11 ± 3 at week 4, no colonies at week 8).
The adherent population represented a smaller number of cells that remained clonogeneic after 3 weeks (fold CFU-GM 12 ± 3 at 4 weeks followed by a decline with no CFU-GM at 8 weeks) suggesting that the more primitive progenitor cells tend to remain in the EC-adherent cell population, giving a committed progeny that detached from the EC monolayer during the coculture. Accordingly, when the non-adherent cell population was regularly removed every week, the adherent cell population gave rise to a new progeny of non-adherent cells. An adherent population of progenitors could be maintained in that way for a period of up to 8 weeks, by replating them after trypsinisation on a fresh EC monolayer (fold cell expansion of the adherent cell population 80 ± 4 at week 4; 2 ± 0.5 at week 8, average ± s.e.m. of three independent experiments).
An important difference between the non-contact and contact cocultures resided in the significantly higher capacity of the contact coculture system to support the proliferation of the nucleated cells and of the CFC. This increased capacity was apparent at times of coculture as early as 5 days. At day 12 there was a significant higher cell proliferation in contact vs non-contact cocultures (average of 3-fold, five independent experiments, P = 0.002). 
Phenotypic analysis of the expanded cell population
In non-contact cocultures, by day 10, more than 80 ± 5% of the expanded cells were myeloid expressing the CD33 antigen and 20 ± 5% were monocytic expressing the CD14 antigen. A very low number of cells stained with the megakaryocytic CD41 antibody. Virtually no staining was observed with lymphoid markers such as CD19. A significant number of mature myeloid cells (5-9% neutrophils) was produced, particularly in cocultures of 2 weeks or longer. At day 10, in contact cocultures, a more important population of cells (15 ± 2%) stained for CD41. Other cells belonged to the myeloid (70 ± 5%) and the monocytic (10 ± 5%) lineages.
IL-1␣ enhances EC competence to support hematopoiesis
We evaluated cell proliferation and CFC generation in noncontact EC cocultures supplemented with IL-1␣ at a final concentration of 100 IU/ml. The addition of IL-1␣ consistently resulted in an average 1.3-, 2-and 3-fold increase in the nucleated cell expansion at days 7, 14 and 21 respectively IL-1 and GC alter EC capacity to support hematopoiesis B Jazwiec et al 1215 (significant at day 21, p = 0.02) (Figure 3a) . CFC generation was also increased in the presence of IL-1␣, by an average 1.5-and 1.6-fold at days 14 and 21 respectively (Figure 3b ). To analyze the direct responsibility of IL-1␣, EC were stimulated for 3 days with IL-1␣, washed free of IL-1␣, and then tested for their capacity to increase the number of hematopoietic cells in a 7-day coculture system. Priming of the EC monolayer with IL-1␣ during 72 h followed by a thorough wash to remove IL-1␣ led to an increased capacity of the EC to support the expansion of nucleated cells. At day 14, there was an approximately 2.6-fold higher cell proliferation in IL-1␣-primed EC, vs non-primed EC (average of four experiments, P = 0.003). Finally, the number of seeded CD34 + cells was an important parameter. In experiments where increasing numbers (1000-12 000) of CD34 + were seeded in the Transwell inserts the effects of IL-1␣ were more marked in the presence of the higher number of cells (not shown).
When analyzed in contact cocultures, the effects of IL-1␣ were again significant on the proliferation of the non-adherent cell population and were responsible for the generation of a very high number of cells (above 4000-fold expansion at day 21) (significant at day 21, P = 0.008) (Figure 4a ). There was a moderate gain in the number of adherent cells at day 14 (not significant) and a loss at day 21 (P = 0.05) (Figure 4c ). In both adherent and non-adherent cell populations IL-1␣ induced a loss of CFC at day 21, compared to day 14. Compared to day 7 there was still a gain in CFU-GM, however not significant (Figure 4b and d) . 
GC are potent suppressors of the EC capacity to support hematopoiesis
Synthetic GC such as DXM added to the cocultures at a concentration of 10 −6 M reduced cell expansion and generation of CFC in both non-contact and contact protocols. The proliferation of nucleated cells and CFC was reduced by an average 2.6-fold and 3.3-fold, respectively at day 21 (P = 0.0008, P = 0.05, respectively) in non-contact cocultures (Figure 3) . In contact cocultures the effects of DXM were even more pronounced with an average 3.2-fold (P = 0.0005) and 6.2-fold (P = 0.01) reduction at day 21 of the proliferation of nucleated cells and CFC in the non-adherent population, respectively and a reduction of 2.7-fold (P = 0.008) and 8.8-fold (P = 0.01) in the adherent cell population, respectively (Figure 4) . Eightweek-old contact or non-contact cocultures in the presence of DXM showed that cell expansion continues to increase until weeks 4-5 before decreasing whereas in control cells it started to decrease at week 3 (fold cell expansion in the presence or absence of DXM 150 ± 3 and 136 ± 4 at week 4 respectively, 3 ± 0.5 and 12.4 ± 4 at week 8 respectively in non-contact cocultures; 223 ± 7 and 326 ± 14 at week 4 respectively and 2.75 ± 0.5 and 26.4 ± 1.6 at week 8 respectively in contact cocultures). Fold CFU-GM expansion at week 4 was 10.5 ± 1 5 in non-contact cocultures in the presence of DXM (11 ± 3 in its absence), 14 ± 1 in contact cocultures in the presence of DXM (11 ± 3 in its absence). Other concentrations of DXM were not investigated. To analyze whether DXM could have a direct inhibitory action on the hematopoietic progenitors, CD34
+ cells from normal cord blood or bone marrow were incubated in the presence of 10% 5637 cell line supernatants or a combination of SCF, IL-3 and IL-1␣ in the presence or absence of 10 −6 m DXM for 7 days. Cells were enumerated and the generation of clonogenic cells was assessed by clonogenic assay in methylcellulose. No differences between control cells and DXM-treated cells could be found, ruling out a direct inhibitory effect of DXM on the progenitor cells (not shown). These results indicated that the suppressive effects of DXM in the EC/progenitor cell cocultures were related to the inhibition of the production of essential cytokines by the EC monolayer. Finally, as judged by the colony phenotype, most CFU-GM (size and day of appearance) generated in the presence of DXM were more primitive than those generated in the absence of DXM. CFU-GM colonies generated in the presence of DXM were large colonies (Ͼ200 cells), whose optimal size was reached only at day 21.
EC conditioned medium and coculture supernatants contain cytokines known to induce the proliferation and differentiation of hematopoietic progenitors: effects of IL-1␣ and GC
Quantitation of cytokines was performed in 3-day-old conditioned medium or at day 14 of contact coculture and showed the presence of IL-6, G-CSF, GM-CSF, M-CSF and LIF (Ref. 46 , not shown) in the supernatants. IL-1␤, IL-3 and IL-7 were not detected. In 3-day-old conditioned medium IL-1␣ stimulated the production of G-CSF (P = 0.002), GM-CSF (P = 0.05), IL-6 (P = 0.02) and M-CSF (P = 0.0006). In 14-dayold coculture supernatants IL-1␣ stimulated the production of G-CSF (P = 0.02), GM-CSF and IL-6. DXM reduced the production of G-CSF, GM-CSF and IL-6 (P = 0.01). Neither IL-1␤, IL-3 nor IL-7 were inducible by IL-1␣ or DXM (Table 1 ). 
Supernatants of EC cultures support in vitro cell expansion and generation of clonogenic cells and this support is inhibited by cytokine neutralizing antibodies
CD34 + isolated progenitors were grown for 7 days in the presence of 25% final concentration of EC supernatants (control or IL-1␣-stimulated). Results showed that EC supernatants were by themselves able to promote the expansion of hematopoietic cells. IL-1␣-stimulated EC supernatants were on average four times more efficient than control supernatants (not shown). When a combination of neutralizing antibodies to IL-1␣, IL-1␤, IL-6, IL-11, G-CSF, GM-CSF, M-CSF, SCF, LIF was added to EC supernatants a major reduction of the EC supernatant-induced proliferation of progenitors was observed. In non-contact cocultures run in the presence of the same combination of neutralizing antibodies, a profound inhibition of the expansion of nucleated cells could also be observed ( Figure 5 ). The reduction in proliferation mainly concerned differentiated cells as there was 3.45 ± 0.5 (average of four experiments, P = 0.001) more CFU-GM in progenitors grown in the presence of the neutralizing antibodies than in their absence. Confirming these results, morphological analysis done at day 14 of the non-contact cocultures showed a striking accumulation of immature progenitors at a myeloblastic and monoblastic stage in the presence of the neutralizing antibodies (24 ± 2% undifferentiated cells, 48 ± 1% myeloblasts, 15 ± 1% promyelocytes, 2.5 ± 1% myelocytes, 11 ± 2% promonocytes in the presence of the antibodies; 4 ± 1% undiffer- Medium was collected from (A) 3-day-old EC cultures, (B) 14-dayold cocultures performed in the presence or not of IL-1␣ (100 IU/ml) or DXM 10 −6 M. Cytokine concentrations (pg/ml) were determined by EIA. UN, undetectable (lower level of detection: 20 pg/ml).
Figure 5
Cytokine neutralizing antibodies suppress EC capacity to support hematopoiesis. CD34
+ cord blood cells were seeded in Transwell inserts and cocultivated with HUVEC for 14 days in the presence (HECnc + Ab) or absence (HECnc) of a combination of polyclonal neutralizing antibodies (Ab) IL-1␣, IL-1␤, IL-6, IL-11, G-CSF, GM-CSF, M-CSF, SCF, LIF at a final concentration of 5 g/ml for each antibody. Cultures were maintained in a fully humidified atmosphere at 37°C and 5% CO 2 and fed twice a week by removing 2 ml of medium from the bottom wells and replacing it with fresh medium with or without the combination of neutralizing antibodies. To control the efficiency of the neutralization, progenitors were grown in the presence of IL-1␣, IL-1␤, IL-6, IL-11, G-CSF, GM-CSF, M-CSF, SCF, LIF (CK) with or without the combination of neutralizing antibodies (CK + Ab). entiated cells, 22 ± 2% myeloblasts, 25 ± 2% promyelocytes, 27.5 ± 2% myelocytes, 21.5 ± 1% monocytes and promonocytes, some macrophages in the control (average of four experiments)). Finally, culture of bone marrow mononuclear or CD34
+ cells in semi-solid medium supplemented with 15% of the coculture supernants also resulted in a significant increase in CFC. We also compared supernatants from EC, IL-1␣-stimulated EC and 5637 bladder carcinoma cell line. Supernatants from IL-1␣-stimulated EC were found to be the most efficient for cell proliferation and generation of CFC (not shown).
Major cell proliferation and generation of CFC is obtained in EC cocultures supplied with exogenous cytokines: potentiation effects of EC supernatants on cytokine-driven expansion
We next sought to establish whether addition of exogenous cytokines to EC/CD34 + cocultures could improve the efficiency of hematopoietic progenitor expansion. IL-3, SCF and IL-1 were first chosen as they are not produced in detectable amounts by the EC monolayer. Results showed a major synergistic increase in cell proliferation and generation of CFC when IL-3, SCF and IL-1␣ were added to the non-contact cocultures compared to the control cocultures (not shown). Finally, as neutralization experiments with antibodies suggested the presence of additional uncharacterized growth factors in EC supernatants, we undertook experiments in which various combinations of cytokines were added to EC supernatants to test the effects of this addition on the proliferation of progenitors. Results show that addition of EC supernatant (6-day-old cultures) at a final concentration of 25% to a combination of IL-1␣, IL-3, IL-6, SCF, LIF, flt3-L, TPO, G-CSF, GM-CSF, M-CSF and IL-11 significantly increased the proliferation of CD34
+ progenitors (HECnc + CK vs HECnc, P = 0.0009 and P = 0.002; HECsup (IL-1) + CK vs HECsup (IL-1), P = 0.001 and P = 0.05 for fold cell expansion and fold CFU-GM expansion respectively) ( Figure 6 ). IL-1␣-stimulated EC supernatants were even more efficient in promoting this potentiation indicating that the putative factors that are responsible for this potentiation were inducible by IL-1␣.
Discussion
EC produce most of the cytokines known to play a role in hematopoiesis. [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] The relationship between the production of these cytokines and the functional ability of EC to support hematopoiesis may help in understanding the role played by these cells in the ontogeny of the hematopoietic system as EC are intimately associated with embryonic hematopoiesis and may be involved in the development of embryonic progenitors. 52, 53 EC are also part of the bone marrow stromal microenvironment. [17] [18] [19] [20] [21] [22] [23] We show that in the absence of added exogenous cytokines, EC support progenitor proliferation and generation of CFC both in a contact and a non-contact coculture system. The pattern of cytokine production is consistent with the phenotypic analysis of the expanded cell population showing essentially the presence of cells of the myeloid and the monocytic lineages. No IL-1, IL-3, IL-7 or EPO are synthetized by these cells. The lack of IL-7 production may explain
Figure 6
Potentiation effects of EC supernatants on cytokinedriven expansion. CD34
+ cord blood cells were grown for 12 days either in the presence of 25% HUVEC supernatant (HEC sup), 25% IL-1␣-stimulated supernatant (HEC sup (IL-1) why these cells failed to support the growth of lymphoid progenitors, and the lack of EPO production may explain why they failed to support the growth of erythroid progenitors. EC seem to be able to support, although to a lesser extent, the proliferation of megakaryocytic progenitors as well (this work, Ref. 49 ). Neutralization experiments demonstrate that these EC-derived cytokines are essential and show a direct relationship between EC capacity to support hematopoiesis and the production of growth factors. These experiments also showed that this neutralization essentially impairs the differentiation of the progenitors but that the more immature cells are still able to proliferate. They suggest that other early acting growth factors are being produced by the EC monolayer. Other factors that may for instance be involved are the flt3-ligand which has been shown to stimulate the growth of primitive hematopoietic cells either alone or in combination. 54, 55 Experiments showing that EC supernatants are able to potentialize the effect of an association of IL-1, IL-6, IL-11, G-CSF, GM-CSF, M-CSF, LIF, SCF, TPO and flt3-ligand may also suggest that still unidentified molecules acting alone or in synergy to support the proliferation of hematopoietic cells are produced by the EC.
Comparative analysis between contact and non-contact cocultures showed a significantly greater efficiency of contact cocultures for maximal production of committed progenitors indicating that additional contact-dependent factors are necessary for optimal expansion of the progenitors. Contactdependent parameters may be the optimized presentation of cytokines via their proteoglycan-mediated immobilization at the EC surface. [56] [57] [58] Alternatively, adhesive interactions between progenitors and EC may promote hematopoietic progenitor proliferation. Adhesive interactions may by themselves promote cell proliferation as has been shown for VLA-4, VLA-5 or VLA-6 when binding to their respective ligands. 59 Adhesive interactions may also alter the way progenitors respond to growth factors. Compared to other sources of feeder cells, EC appear to be more efficient in expanding hematopoietic progenitors in short-term cultures. However, longterm EC cocultures show exhaustion of the primitive progenitors and suggest that classical long-term bone marrow cultures remain superior in the maintenance of this population.
The lag time between the seeding of the progenitor cells and the initiation of cell proliferation indicates that expansion is dependent on an appropriate threshold concentration of these growth factors. Accordingly, IL-1␣ increased their production and reduced this lag time and IL-1␣-prestimulated EC were more efficient in supporting this expansion than unstimulated cells. IL-1 is known to stimulate the secretion by EC of cytokines, some of them having functional importance in hematopoiesis such as IL-6, 60 colony-stimulating factors 61, 62 or more recently LIF. 13, 41 Although a direct effect of IL-1␣ on the progenitors cannot be ruled out, 63 our results suggest that it is mainly acting through the modulation of cytokine production by the stromal layer. These observations could be of interest for protocols using endothelialized biomatrix as a source of feeder cells for ex vivo expansion of hematopoietic progenitors as the use of IL-1 may significantly increase the biomatrix competence.
The inhibitory effects of GC on cell proliferation and generation of CFC help to understand the complex effects that these compounds have on hematopoiesis. GC have been shown to decrease the production of some hematopoiesis-promoting cytokines by EC. IL-6 [64] [65] and LIF 47 for instance, are downregulated by GC. Our results show that the production of IL-6, G-CSF and GM-CSF are reduced by DXM in EC/hematopoietic progenitor cocultures. This GC-induced reduction in cytokine production is consequent with the impairment of primitive progenitors to differentiate and proliferate in the presence of DXM. Accordingly, progenitors generated in the presence of DXM were more primitive. GC have been shown to decrease the frequency and the clonogenic progeny of LTC-ICs cultured on MS-5, a murine marrow-derived stroma cell line but not on LTBMC-derived human stroma. The authors discussed the possible inhibition by DXM of a synergistic factor produced by MS-5. 66 This mechanism could also be operating for EC. In vivo, administration of GC to man results in a shift of the pattern of circulating leukocytes, mostly a decrease in the number of monocytes, basophils, eosinophils and lymphocytes. In contrast, neutrophil number is elevated. 67 This effect, however, is probably secondary to a mobilization of the marginated pool of leukocytes, as GC are strong inhibitors of the expression of cell adhesion molecules at the surface of the endothelium. 68 Results of this study also suggest that EC-conditioned medium might be used as a standardized source of growth factors. The ex vivo expansion of bone marrow progenitor cells has important applications for bone marrow transplantation where rapid recovery of blood cell counts is desirable. The transplantation of large numbers of CFU-GM has been shown to result in rapid hematopoietic recovery. The transplantation of large numbers of more mature cells is also desirable to quickly restore a sufficient number of granulocytes. EC-conditioned medium might therefore have a potential clinical interest for ex vivo expansion protocols of peripheral blood stem cells (PBSCs) aiming at increasing quantity and quality of PBSCs required for successful hematopoietic recovery after myeloablative therapy. Another potential interest is that these supernatants appear to contain still unidentified hematopoiesis-promoting growth factors that may be more generally produced by EC from different sources. 69 
